Hsbc Holdings PLC Has $80.47 Million Position in The Clorox Company (NYSE:CLX)

Hsbc Holdings PLC boosted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 496,117 shares of the company's stock after acquiring an additional 34,703 shares during the quarter. Hsbc Holdings PLC owned about 0.40% of Clorox worth $80,474,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of CLX. Integral Investment Advisors Inc. boosted its stake in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock valued at $279,000 after buying an additional 67 shares during the period. HCR Wealth Advisors raised its holdings in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock worth $1,116,000 after acquiring an additional 68 shares in the last quarter. Sound View Wealth Advisors Group LLC boosted its position in Clorox by 6.1% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock valued at $218,000 after purchasing an additional 77 shares during the last quarter. Wedbush Securities Inc. raised its stake in shares of Clorox by 1.2% during the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock worth $1,238,000 after purchasing an additional 94 shares in the last quarter. Finally, Brooklyn Investment Group lifted its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after buying an additional 95 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of NYSE:CLX traded up $1.62 during trading on Tuesday, reaching $140.40. The stock had a trading volume of 998,897 shares, compared to its average volume of 1,301,533. The stock has a market capitalization of $17.30 billion, a PE ratio of 38.37, a P/E/G ratio of 2.62 and a beta of 0.61. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The business's 50-day moving average price is $145.37 and its 200 day moving average price is $155.48.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company earned $2.16 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.48%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CLX. Citigroup reduced their target price on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. UBS Group decreased their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. DA Davidson decreased their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $153.83.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.